Synthesis and biological evaluation of imidazo[2,1-b]thiazole-benzimidazole conjugates as microtubule-targeting agents. 2018

Mirza Feroz Baig, and V Lakshma Nayak, and Prasad Budaganaboyina, and Kishore Mullagiri, and Satish Sunkari, and Jitendra Gour, and Ahmed Kamal
Medicinal Chemistry and Biotechnology Division, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad 500007, India; Academy of Scientific and Innovative Research, New Delhi 110 025, India.

A series of imidazo[2,1-b]thiazole-benzimidazole conjugates were synthesized and evaluated for their antiproliferative activity against four human cancer cell lines i.e.; HeLa (cervical), A549 (lung), MCF-7 (breast) and DU-145 (prostate) along with normal HEK-293 cell line. Amongst them, conjugate 6d displayed significant cytotoxicity against human lung cancer cell line, A549 with IC50 value 1.08 µM. Further, cell cycle analysis revealed that this compound arrested the cell cycle at G2/M phase in A549 cells. Furthermore, the tubulin polymerization assay results suggest that this conjugate (6d) exhibits significant inhibitory effect on the tubulin assembly with an IC50 value of 1.68 µM. Moreover, the apoptotic inducing properties of compound 6d was confirmed by Hoechst staining, measurement of mitochondrial membrane potential (ΔΨm) and annexin V-FITC assay. Further, molecular docking studies revealed that compound 6d occupied the colchicine binding site.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008870 Microtubules Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS. Microtubule
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Mirza Feroz Baig, and V Lakshma Nayak, and Prasad Budaganaboyina, and Kishore Mullagiri, and Satish Sunkari, and Jitendra Gour, and Ahmed Kamal
February 2018, Bioorganic chemistry,
Mirza Feroz Baig, and V Lakshma Nayak, and Prasad Budaganaboyina, and Kishore Mullagiri, and Satish Sunkari, and Jitendra Gour, and Ahmed Kamal
December 2014, ChemMedChem,
Mirza Feroz Baig, and V Lakshma Nayak, and Prasad Budaganaboyina, and Kishore Mullagiri, and Satish Sunkari, and Jitendra Gour, and Ahmed Kamal
January 2017, European journal of medicinal chemistry,
Mirza Feroz Baig, and V Lakshma Nayak, and Prasad Budaganaboyina, and Kishore Mullagiri, and Satish Sunkari, and Jitendra Gour, and Ahmed Kamal
August 2022, RSC advances,
Mirza Feroz Baig, and V Lakshma Nayak, and Prasad Budaganaboyina, and Kishore Mullagiri, and Satish Sunkari, and Jitendra Gour, and Ahmed Kamal
December 2015, Bioorganic chemistry,
Mirza Feroz Baig, and V Lakshma Nayak, and Prasad Budaganaboyina, and Kishore Mullagiri, and Satish Sunkari, and Jitendra Gour, and Ahmed Kamal
March 2016, Bioorganic & medicinal chemistry,
Mirza Feroz Baig, and V Lakshma Nayak, and Prasad Budaganaboyina, and Kishore Mullagiri, and Satish Sunkari, and Jitendra Gour, and Ahmed Kamal
January 2019, Anti-cancer agents in medicinal chemistry,
Mirza Feroz Baig, and V Lakshma Nayak, and Prasad Budaganaboyina, and Kishore Mullagiri, and Satish Sunkari, and Jitendra Gour, and Ahmed Kamal
January 2022, Medicinal chemistry (Shariqah (United Arab Emirates)),
Mirza Feroz Baig, and V Lakshma Nayak, and Prasad Budaganaboyina, and Kishore Mullagiri, and Satish Sunkari, and Jitendra Gour, and Ahmed Kamal
March 2020, Bioorganic chemistry,
Mirza Feroz Baig, and V Lakshma Nayak, and Prasad Budaganaboyina, and Kishore Mullagiri, and Satish Sunkari, and Jitendra Gour, and Ahmed Kamal
February 2014, Steroids,
Copied contents to your clipboard!